Selected research
Industry Research
Pet Vaccine Industry Research Report 2026
Market perspective
The global Pet Vaccine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Pet Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Pet Vaccine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Pet Vaccine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Pet Vaccine include CAHIC, Zoetis, Ringpu, Merck Animal Health, Keqian Biology, Jinyu Group, Virbac, Vetoquinol and Parnell, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Pet Vaccine market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pet Vaccine Market by Company
CAHIC
Zoetis
Ringpu
Merck Animal Health
Keqian Biology
Jinyu Group
Virbac
Vetoquinol
Parnell
Ouro Fino Saude
Meiji
Kyoritsu Seiyaku
Elanco Animal Health
Dechra Veterinary Products
Ceva
Boehringer Ingelheim
Animalcare Group
Pet Vaccine Segment by Type
Nasal Administration
Injection
Other
Pet Vaccine Segment by Application
Cat
Dog
Other
Pet Vaccine Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pet Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Pet Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Pet Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Pet Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Nasal Administration
- Injection
- Other
Applications
- Cat
- Dog
- Other
Companies covered
- CAHIC
- Zoetis
- Ringpu
- Merck Animal Health
- Keqian Biology
- Jinyu Group
- Virbac
- Vetoquinol
- Parnell
- Ouro Fino Saude
- Meiji
- Kyoritsu Seiyaku
- Elanco Animal Health
- Dechra Veterinary Products
- Ceva
- Boehringer Ingelheim
- Animalcare Group
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Pet Vaccine Market Size (2021-2032)
- 2.2.2 Global Pet Vaccine Sales (2021-2032)
- 2.2.3 Global Pet Vaccine Market Average Price (2021-2032)
- 2.3 Pet Vaccine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Nasal Administration
- 2.3.3 Injection
- 2.3.4 Other
- 2.4 Pet Vaccine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Cat
- 2.4.3 Dog
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Pet Vaccine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Pet Vaccine Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Pet Vaccine Revenue of Manufacturers (2021-2026)
- 3.4 Global Pet Vaccine Average Price by Manufacturers (2021-2026)
- 3.5 Global Pet Vaccine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Pet Vaccine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Pet Vaccine, Product Type & Application
- 3.8 Global Manufacturers of Pet Vaccine, Established Date
- 3.9 Global Pet Vaccine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 CAHIC
- 4.1.1 CAHIC Company Information
- 4.1.2 CAHIC Business Overview
- 4.1.3 CAHIC Pet Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 CAHIC Pet Vaccine Product Portfolio
- 4.1.5 CAHIC Recent Developments
- 4.2 Zoetis
- 4.2.1 Zoetis Company Information
- 4.2.2 Zoetis Business Overview
- 4.2.3 Zoetis Pet Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Zoetis Pet Vaccine Product Portfolio
- 4.2.5 Zoetis Recent Developments
- 4.3 Ringpu
- 4.3.1 Ringpu Company Information
- 4.3.2 Ringpu Business Overview
- 4.3.3 Ringpu Pet Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Ringpu Pet Vaccine Product Portfolio
- 4.3.5 Ringpu Recent Developments
- 4.4 Merck Animal Health
- 4.4.1 Merck Animal Health Company Information
- 4.4.2 Merck Animal Health Business Overview
- 4.4.3 Merck Animal Health Pet Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Merck Animal Health Pet Vaccine Product Portfolio
- 4.4.5 Merck Animal Health Recent Developments
- 4.5 Keqian Biology
- 4.5.1 Keqian Biology Company Information
- 4.5.2 Keqian Biology Business Overview
- 4.5.3 Keqian Biology Pet Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Keqian Biology Pet Vaccine Product Portfolio
- 4.5.5 Keqian Biology Recent Developments
- 4.6 Jinyu Group
- 4.6.1 Jinyu Group Company Information
- 4.6.2 Jinyu Group Business Overview
- 4.6.3 Jinyu Group Pet Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Jinyu Group Pet Vaccine Product Portfolio
- 4.6.5 Jinyu Group Recent Developments
- 4.7 Virbac
- 4.7.1 Virbac Company Information
- 4.7.2 Virbac Business Overview
- 4.7.3 Virbac Pet Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Virbac Pet Vaccine Product Portfolio
- 4.7.5 Virbac Recent Developments
- 4.8 Vetoquinol
- 4.8.1 Vetoquinol Company Information
- 4.8.2 Vetoquinol Business Overview
- 4.8.3 Vetoquinol Pet Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Vetoquinol Pet Vaccine Product Portfolio
- 4.8.5 Vetoquinol Recent Developments
- 4.9 Parnell
- 4.9.1 Parnell Company Information
- 4.9.2 Parnell Business Overview
- 4.9.3 Parnell Pet Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Parnell Pet Vaccine Product Portfolio
- 4.9.5 Parnell Recent Developments
- 4.10 Ouro Fino Saude
- 4.10.1 Ouro Fino Saude Company Information
- 4.10.2 Ouro Fino Saude Business Overview
- 4.10.3 Ouro Fino Saude Pet Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Ouro Fino Saude Pet Vaccine Product Portfolio
- 4.10.5 Ouro Fino Saude Recent Developments
- 4.11 Meiji
- 4.11.1 Meiji Company Information
- 4.11.2 Meiji Business Overview
- 4.11.3 Meiji Pet Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Meiji Pet Vaccine Product Portfolio
- 4.11.5 Meiji Recent Developments
- 4.12 Kyoritsu Seiyaku
- 4.12.1 Kyoritsu Seiyaku Company Information
- 4.12.2 Kyoritsu Seiyaku Business Overview
- 4.12.3 Kyoritsu Seiyaku Pet Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Kyoritsu Seiyaku Pet Vaccine Product Portfolio
- 4.12.5 Kyoritsu Seiyaku Recent Developments
- 4.13 Elanco Animal Health
- 4.13.1 Elanco Animal Health Company Information
- 4.13.2 Elanco Animal Health Business Overview
- 4.13.3 Elanco Animal Health Pet Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Elanco Animal Health Pet Vaccine Product Portfolio
- 4.13.5 Elanco Animal Health Recent Developments
- 4.14 Dechra Veterinary Products
- 4.14.1 Dechra Veterinary Products Company Information
- 4.14.2 Dechra Veterinary Products Business Overview
- 4.14.3 Dechra Veterinary Products Pet Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Dechra Veterinary Products Pet Vaccine Product Portfolio
- 4.14.5 Dechra Veterinary Products Recent Developments
- 4.15 Ceva
- 4.15.1 Ceva Company Information
- 4.15.2 Ceva Business Overview
- 4.15.3 Ceva Pet Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Ceva Pet Vaccine Product Portfolio
- 4.15.5 Ceva Recent Developments
- 4.16 Boehringer Ingelheim
- 4.16.1 Boehringer Ingelheim Company Information
- 4.16.2 Boehringer Ingelheim Business Overview
- 4.16.3 Boehringer Ingelheim Pet Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Boehringer Ingelheim Pet Vaccine Product Portfolio
- 4.16.5 Boehringer Ingelheim Recent Developments
- 4.17 Animalcare Group
- 4.17.1 Animalcare Group Company Information
- 4.17.2 Animalcare Group Business Overview
- 4.17.3 Animalcare Group Pet Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Animalcare Group Pet Vaccine Product Portfolio
- 4.17.5 Animalcare Group Recent Developments
5 Global Pet Vaccine Market Scenario by Region
- 5.1 Global Pet Vaccine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Pet Vaccine Sales by Region: 2021-2032
- 5.2.1 Global Pet Vaccine Sales by Region: 2021-2026
- 5.2.2 Global Pet Vaccine Sales by Region: 2027-2032
- 5.3 Global Pet Vaccine Revenue by Region: 2021-2032
- 5.3.1 Global Pet Vaccine Revenue by Region: 2021-2026
- 5.3.2 Global Pet Vaccine Revenue by Region: 2027-2032
- 5.4 North America Pet Vaccine Market Facts & Figures by Country
- 5.4.1 North America Pet Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Pet Vaccine Sales by Country (2021-2032)
- 5.4.3 North America Pet Vaccine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Pet Vaccine Market Facts & Figures by Country
- 5.5.1 Europe Pet Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Pet Vaccine Sales by Country (2021-2032)
- 5.5.3 Europe Pet Vaccine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Pet Vaccine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Pet Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Pet Vaccine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Pet Vaccine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Pet Vaccine Market Facts & Figures by Country
- 5.7.1 South America Pet Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Pet Vaccine Sales by Country (2021-2032)
- 5.7.3 South America Pet Vaccine Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Pet Vaccine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Pet Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Pet Vaccine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Pet Vaccine Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Pet Vaccine Sales by Type (2021-2032)
- 6.1.1 Global Pet Vaccine Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Pet Vaccine Sales Market Share by Type (2021-2032)
- 6.2 Global Pet Vaccine Revenue by Type (2021-2032)
- 6.2.1 Global Pet Vaccine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Pet Vaccine Revenue Market Share by Type (2021-2032)
- 6.3 Global Pet Vaccine Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Pet Vaccine Sales by Application (2021-2032)
- 7.1.1 Global Pet Vaccine Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Pet Vaccine Sales Market Share by Application (2021-2032)
- 7.2 Global Pet Vaccine Revenue by Application (2021-2032)
- 7.2.1 Global Pet Vaccine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Pet Vaccine Revenue Market Share by Application (2021-2032)
- 7.3 Global Pet Vaccine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Pet Vaccine Value Chain Analysis
- 8.1.1 Pet Vaccine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Pet Vaccine Production Mode & Process
- 8.2 Pet Vaccine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Pet Vaccine Distributors
- 8.2.3 Pet Vaccine Customers
9 Global Pet Vaccine Analyzing Market Dynamics
- 9.1 Pet Vaccine Industry Trends
- 9.2 Pet Vaccine Industry Drivers
- 9.3 Pet Vaccine Industry Opportunities and Challenges
- 9.4 Pet Vaccine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst